Aerie Pharmaceuticals (AERI)

Aerie Pharma (AERI) Financial Statements


Aerie Pharma Financial Overview

Aerie Pharma's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Aerie Pharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 36.13M$ 33.31M$ 29.84M$ 114.67M$ 29.31M
Gross Profit$ 29.20M$ 29.57M$ 23.05M$ 108.60M$ 21.41M
EBIT$ -25.08M$ -18.14M$ -33.56M$ 53.54M$ -32.27M
EBITDA$ -21.73M$ -14.71M$ -29.95M$ 63.33M$ -22.67M
Net Income Common Stockholders$ -26.83M$ -19.37M$ -35.89M$ 45.53M$ -39.69M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 172.46M$ 184.37M$ 195.25M$ 139.80M$ 167.61M
Total Assets$ 375.59M$ 385.34M$ 395.55M$ 431.39M$ 351.80M
Total Debt$ 336.99M$ 337.29M$ 337.18M$ 260.64M$ 254.62M
Net Debt$ 164.52M$ 152.92M$ 141.93M$ 120.84M$ 87.01M
Total Liabilities$ 539.57M$ 526.47M$ 521.26M$ 448.72M$ 424.68M
Stockholders Equity$ -163.98M$ -141.13M$ -125.71M$ -17.33M$ -72.88M
Cash Flow-
Free Cash Flow$ -12.21M$ -14.60M$ 60.31M$ -30.86M$ -20.01M
Operating Cash Flow$ -11.40M$ -13.23M$ 61.91M$ -30.11M$ -18.85M
Investing Cash Flow$ 25.86M$ -3.93M$ -42.30M$ 2.06M$ 1.13M
Financing Cash Flow$ 188.00K$ 166.00K$ -357.00K$ 3.39M$ -390.00K
Currency in USD

Aerie Pharma Earnings and Revenue History

Aerie Pharma Debt to Assets

Aerie Pharma Cash Flow

Aerie Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis